ArticleIndian journal of thoracic and cardiovascular surgery2025
Extracorporeal membrane oxygenation as a bridge to lung transplantation following paraquat poisoning.
Article in Indian journal of thoracic and cardiovascular surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A retrospective analysis of paraquat and diquat poisoning: a single-center experience.Frontiers in medicine · 2026Article
- Case Report: Multifactorial weaning failure after lung transplantation in paraquat-induced pulmonary fibrosis: a case-based clinical review.Frontiers in medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Paraquat poisoning contributes to nearly 14.4% of the total poisoning cases in southern India. When ingested, it leads to renal and liver damage. It accumulates in alveolar cells and through reactive oxygen species damage, it can lead to pulmonary fibrosis. Once pulmonary fibrosis is established, the ensuing respiratory failure is irreversible. The previously reported duration of extracorporeal membrane oxygenation (ECMO) to support the respiratory function in paraquat poisoning, as a bridge to lung transplantation, ranged between 1 and 2 days. We demonstrate the use of long-term awake veno-venous (VV) ECMO in two patients (70 and 67 days), after paraquat poisoning as a bridge to lung transplantation. We describe the advantages of awake ECMO in patients requiring extended ECMO support mainly in the form of nutritional, physical, and psychiatric rehabilitation. This is of importance in these patients, and awake ECMO provides an excellent method to achieve an optimum physical status prior to lung transplantation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.